Flu season is in full effect. Are you ready? The CDC estimates between 9.2 million and 35.6 million flu illnesses each year in the United States. While getting a flu shot is suggested, some people are too late to get it and may eventually get sick. In years past, we have seen that the medication, Tamiflu, is constantly on back order and a rare find. Thankfully the FDA has approved a new medication, Xofluza (baloxavir marboxil), for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.
“This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years. With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical. This novel drug provides an important, additional treatment option,” said FDA Commissioner Scott Gottlieb, M.D. “While there are several FDA-approved antiviral drugs to treat flu, they’re not a substitute for yearly vaccination. Flu season is already well underway, and the U.S. Centers for Disease Control and Prevention recommends getting vaccinated by the end of October, as seasonal flu vaccine is one of the most effective and safest ways to protect yourself, your family and your community from the flu and serious flu-related complications, which can result in hospitalizations. Yearly vaccination is the primary means of preventing and controlling flu outbreaks.”
To read more about Xofluza and the FDA’s plan, click this link.